Cohort of Nursing Homes
1 other identifier
observational
1,500
1 country
1
Brief Summary
The goal of this observational study was to establish cohorts of elderly people in hospital care and elderly people in home care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2023
CompletedFirst Submitted
Initial submission to the registry
August 1, 2025
CompletedFirst Posted
Study publicly available on registry
November 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
November 25, 2025
November 1, 2024
3.1 years
August 1, 2025
November 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health status of elderly people
The diseases status of elderly people, including chronic diseases, cancers, and priority diseases.
The diseases status of elderly people will be assessed at baseline and at follow-up visits every 3 to 5 years.
Study Arms (2)
Elderly people in medical-nursing care
The elderly people residing in retirement communities with medical facilities
Elderly people in home care
The elderly people receiving home care
Eligibility Criteria
Elderly people residing in retirement communities with medical facilities and people receiving home care.
You may qualify if:
- Voluntarily participated in this study and provided signed informed consent forms.
- Both male and female.
- Age 60 years old and above.
You may not qualify if:
- Unable to participate in physical examinations due to being bedridden or having limited mobility.
- Unable to communicate effectively.
- People cannot participate for other reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Hematology & Blood Diseases Hospital
Tianjin, 300000, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2025
First Posted
November 25, 2025
Study Start
November 30, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2030
Last Updated
November 25, 2025
Record last verified: 2024-11